Siga Technologies Inc Revenue Growth Rates (SIGAQ), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Siga Technologies Inc  (SIGAQ)
 

SIGAQ's Revenue Growth by Quarter and Year

Siga Technologies Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SIGAQ Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
4th Quarter December 4.26
3rd Quarter September 8.11
2nd Quarter June 3.91
1st Quarter March 471.08
FY 487.36





SIGAQ Revenue fourth quarter 2018 Y/Y Growth Comment
Siga Technologies Inc achieved in the fourth quarter 2018, above Company average Revenue rise of 60.3% year on year, to $ 4.26 millions.

Looking into fourth quarter 2018 results within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue growth. While Siga Technologies Inc' s Revenue jump of 60.3% ranks overall at the positon no. 384 in the fourth quarter 2018.


SIGAQ Revenue ( Y/Y Growth %) 2018
 2017 2016 2015
4th Quarter December 60.3 % 100 % - -
3rd Quarter September 363.43 % 19.05 % - -
2nd Quarter June 105.79 % 59.66 % - -
1st Quarter March 36992.91 % - - -
FY   6329.6 % 89.97 % - -

Financial Statements
Siga Technologies Inc's fourth quarter 2018 Revenue $ 4.26 millions SIGAQ's Income Statement
Siga Technologies Inc's fourth quarter 2017 Revenue $ 2.66 millions Quarterly SIGAQ's Income Statement


SIGAQ Revenue (Quarter on Quarter Growth %)

 2018
 2017 2016 2015
4th Quarter December -47.42 % 52 % -9.52 % -
3rd Quarter September 107.42 % -7.89 % 23.53 % -
2nd Quarter June -99.17 % 49.61 % - -
1st Quarter March 17609.77 % -4.51 % - -
FY (Year on Year)   6329.6 % 89.97 % - -


Back to SIGAQ Growth rate Comparisons >> Back to SIGAQ Growth rate Comparisons >>


Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #62
Healthcare Sector #105
Overall #384

Revenue Y/Y Growth Statistics
High Average Low
46.84 % -3.84 % -98.28 %
(Jun 30 2019)   (Sep 30 2019)
Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #62
Healthcare Sector #105
Overall #384
Revenue Y/Y Growth Statistics
High Average Low
46.84 % -3.84 % -98.28 %
(Jun 30 2019)   (Sep 30 2019)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Siga Technologies Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
17601.51 % 2539.6 % -47.43 %
(Sep 30 2018)  


SIGAQ's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2018 Siga Technologies Inc disclosed fall in Revenue from the third quarter by -47.42% to $ 4.26 millions, from $ 8.11 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2018 Revenue, this plainly could not be substantial to rescue 's company achievement, Most analysts pointed out.

Within Major Pharmaceutical Preparations industry 255 other companies have achieved higher Revenue quarter on quarter growth. While Siga Technologies Inc's Revenue growth quarter on quarter, overall rank is 4392.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #256
Healthcare Sector #627
Overall #4392
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #256
Healthcare Sector #627
Overall #4392
Revenue Q/Q Growth Statistics
High Average Low
17601.51 % 2539.6 % -47.43 %
(Sep 30 2018)  


SIGAQ's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2018 Siga Technologies Inc disclosed fall in Revenue from the third quarter by -47.42% to $ 4.26 millions, from $ 8.11 millions achived in the previous reporting period.

Although periodic circumstance commonly energize IV. Quarter 2018 Revenue, this plainly could not be substantial to rescue 's company achievement, Most analysts pointed out.

Within Major Pharmaceutical Preparations industry 255 other companies have achieved higher Revenue quarter on quarter growth. While Siga Technologies Inc's Revenue growth quarter on quarter, overall rank is 4392.


Siga Technologies Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Sep 30 2019)		 12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Sep 30 2018)		 12 Months Ending
(Jun 30 2018)
Cumulative Revenue 12 Months Ending $ 487.36 $ 485.76 $ 479.39 $ 477.39 $ 7.58
Y / Y Revenue Growth (TTM) 6329.36 % 7676.59 % 7935.52 % 8981.49 % -
Year on Year Revenue Growth Overall Ranking # 6 # # # 4 # 4
Seqeuential Revenue Change (TTM) 0.33 % 1.33 % 0.42 % 6197.8 % 21.35 %
Seq. Revenue Growth (TTM) Overall Ranking # 6 # # # 4 #


Cumulative Revenue growth Comment
Assuming the Siga Technologies Inc's fiscal year would have ended in Dec 31 2019, Siga Technologies Inc would have reprted above average annual Revenue surge of 6329.36% year on year, of $ 487 millions.
This marks a slow-down of the companys growth trends and from the 7676.59% surge in Sep 30 2019. But looking into other companies within Major Pharmaceutical Preparations industry, just one company had higher Revenue growth.

Looking into Healthcare sector trailing twelve month Revenue increase, only one company had higher growth. While Revenue growth total ranking has deteriorated compare to previous quarter from to 6.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 2
Overall # 4

Revenue TTM Y/Y Growth Statistics
High Average Low
8981.49 %
 4414.47 %
-74.85 %
(Sep 30 2018)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 103
Sector # 202
S&P 500 # 952
Cumulative Revenue growth Comment
Assuming the Siga Technologies Inc's fiscal year would have ended in Dec 31 2019, Siga Technologies Inc would have reprted above average annual Revenue surge of 6329.36% year on year, of $ 487 millions.
This marks a slow-down of the companys growth trends and from the 7676.59% surge in Sep 30 2019. But looking into other companies within Major Pharmaceutical Preparations industry, just one company had higherRevenue growth.

Looking into Healthcare sector trailing twelve month Revenue increase, only one company had higher growth. While Revenue growth total ranking has deteriorated compare to previous quarter from to 6.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 2
Overall # 4

Revenue TTM Y/Y Growth Statistics
High Average Low
8981.49 %
4414.47 %
-74.85 %
(Sep 30 2018)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 103
Sector # 202
S&P 500 # 952




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SIGAQ's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2019
Sangamo Therapeutics Inc 104.39%$ 104.386 millions
Antares Pharma Inc 101.05%$ 101.047 millions
Editas Medicine Inc 100.75%$ 100.752 millions
Dynavax Technologies Corporation98.76%$ 98.759 millions
Nephros Inc 96.09%$ 96.092 millions
Misonix Inc 93.80%$ 93.800 millions
Guardant Health Inc 91.33%$ 91.333 millions
Portola Pharmaceuticals inc 91.19%$ 91.188 millions
Accelerate Diagnostics Inc 90.45%$ 90.450 millions
Precision Optics Corporation Inc 89.25%$ 89.245 millions
Sorrento Therapeutics Inc 88.11%$ 88.108 millions
Elite Pharmaceuticals Inc 87.65%$ 87.646 millions
Theravance Biopharma inc 87.45%$ 87.450 millions
Neurocrine Biosciences Inc 85.57%$ 85.570 millions
Amarin Corp Plcuk85.28%$ 85.282 millions
Miragen Therapeutics Inc 84.87%$ 84.874 millions
Electrocore Inc 83.62%$ 83.624 millions
Sanuwave Health Inc 83.05%$ 83.050 millions
Lifemd Inc 80.56%$ 80.559 millions
Kyto Technology And Life Science Inc 80.00%$ 80.000 millions
Tivity Health Inc 78.25%$ 78.250 millions
Aytu Biopharma Inc76.89%$ 76.892 millions
Biodelivery Sciences International Inc 75.49%$ 75.488 millions
Serina Therapeutics Inc 75.40%$ 75.399 millions
La Jolla Pharmaceutical Company73.28%$ 73.279 millions
Ra Pharmaceuticals Inc 72.56%$ 72.560 millions
Axim Biotechnologies Inc 71.48%$ 71.483 millions
T2 Biosystems Inc 71.26%$ 71.261 millions
Myomo Inc 70.95%$ 70.946 millions
Transmedics Group Inc 70.91%$ 70.909 millions


About Siga Technologies Inc Revenue Growth Rates (SIGAQ), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Siga Technologies Inc (CIK 1010086).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-026314
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Siga Technologies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.